Safety Information

Do not use semaglutide or tirzepatide if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, if you have had a serious allergic reaction to a GLP-1 receptor agonist, or if you are pregnant, breastfeeding or trying to conceive.

Tell your clinician if you have a history of pancreatitis, gastroparesis or other severe gastrointestinal disease, diabetic retinopathy, gallbladder disease, or an active eating disorder.

Nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, injection-site reactions and reduced appetite are the most commonly reported effects. Most are dose-related and improve as your body adjusts.

Serious but uncommon risks include pancreatitis, gallbladder disease, kidney injury from dehydration, low blood sugar (especially alongside insulin or sulfonylureas), and allergic reactions. Stop treatment and seek care immediately for severe abdominal pain, persistent vomiting, or signs of an allergic reaction.

Your clinician sets a starting dose and titration schedule based on your history and response. Do not increase your dose on your own, and never share medication with another person.

Report new or worsening symptoms promptly through your Velos care team so your dose can be adjusted or treatment stopped.

Some medications prescribed through Velos Health are compounded by a state-licensed pharmacy. Compounded drugs are not reviewed or approved by the FDA for safety, effectiveness or manufacturing quality.

Compounded medications are shipped only when clinically appropriate for you and only pursuant to a valid prescription from a licensed clinician.

Velos Health does not provide emergency care. If you believe you are having a medical emergency, call 911 or go to the nearest emergency department. For mental health crises, call or text 988.